NUCLEIC ACID ISOLATION AND PURIFICATION MARKET ANALYSIS
Nucleic Acid Isolation and Purification Market Drivers
Increasing demand for nucleic acid test that is required for pipeline studies of genetic engineering and molecular diagnostics is the key driver for nucleic acid isolation and purification market growth. For Instance, in September 2012, GlaxoSmithKline initiated Phase 1 clinical study to evaluate the effects of chemotherapy and adoptive immunotherapy with T cells engineered to recognize NY-ESO-1 peptide in patients with unresectable, metastatic or recurrent synovial sarcoma. T immune cells are genetically engineered to express tumor-specific T cell receptor (TCR) genes and thereby kill cancer cells. The study is expected to complete by May 2020.
Nucleic Acid Isolation and Purification Market- Regional Analysis
On the basis of region, the global nucleic acid isolation and purification market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Increasing merger and acquisition activities in North America are expected to drive the nucleic acid isolation and purification market size. For Instance, in May 2018, Agilent Technologies Inc. acquired Lasergen, Inc. in a US$ 105 million deal. The collaboration has been done to develop next-generation sequencing workflow solutions for clinical applications.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
